References

Abedi, G. and F. Rostami, 2012. Regression model analysis of service desirability in a group of Mazandaran hospitals. HealthMED, 6: 24-28.
Direct Link  |  

Abedi, G., A. Mohammadi, F. Mohammadi, A.Alizadeh, H. Hosseini et al., 2012. University students' personality profile based on Casta and MaCrea five factor theory Intl. J. Collaborative Res. Internal Med. Public Health, 4: 1330-1336.
Direct Link  |  

Battistuzzi, G., D.M. Urso, D. Toniolo, G.M. Persico and L. Luzzatto, 1985. Tissue-specific levels of human glucose-6-phosphate dehydrogenase correlate with methylation of specific sites at the 3'end of the gene. Proc. National Acad. Sci., 82: 1465-1469.
Direct Link  |  

Beutler, E., 1991. Glucose-6-phosphate dehydrogenase deficiency. N. Engl. J. Med., 324: 169-174.

Beutler, E., 1994. G6PD deficiency. Blood New York, 84: 3613-3613.
Direct Link  |  

Blackburn, H., 1991. The potential for prevention of atherosclerosis in childhood. Ann. New York Acad. Sci., 623: 2-8.
CrossRef  |  Direct Link  |  

Cannon, C.P., E. Braunwald, C.H. McCabe, D.J. Rader and J.L. Rouleau et al., 2004. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. New Eng. J. Med., 350: 1495-1504.
Direct Link  |  

Chan, T.K., D. Todd and C.C. Wong, 1965. Tissue enzyme levels in erythrocyte glucose-6-phosphate dehydrogenase deficiency. J. Lab. Clini. Med., 66: 937-942.
Direct Link  |  

Cocco, P., P. Todde, S. Fornera, M.B. Manca and P. Manca et al., 1998. Mortality in a cohort of men expressing the glucose-6-phosphate dehydrogenase deficiency. Blood, 91: 706-709.
Direct Link  |  

Downs, J.R., M. Clearfield, S. Weis, E. Whitney and D.R. Shapiro et al., 1998. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Air force/Texas coronary atherosclerosis prevention study. J. Am. Med. Assoc., 279: 1615-1622.
CrossRef  |  PubMed  |  Direct Link  |  

Endres, M., 2006. Statins: Potential new indications in inflammatory conditions. Atherosclerosis Suppl., 7: 31-35.
Direct Link  |  

Khalesy, N., N. Khosravi and M. Haghighi, 2012. Prevalence of glucose -6–phosphate dehydrogenase deficiency in neonates born in Tehran-Iran. J. Gorgan Uni. Med. Sci., 14: 100-105.

Kirkman, H.N., 1968. Glucose-6-phosphate dehydrogenase variants and drug-induced hemolysis. Ann. New York Acad. Sci., 151: 753-764.
CrossRef  |  Direct Link  |  

Leopold, J.A., A. Cap, A.W. Scribner, R.C. Stanton and J. Loscalzo, 2001. Glucose-6-phosphate dehydrogenase deficiency promotes endothelial oxidant stress and decreases endothelial nitric oxide bioavailability. FASEB J., 15: 1771-1773.
Direct Link  |  

Livingstone, F.B., 1985. Frequencies of Hemoglobin Variants: Thalassemia, The Glucose-6-Phosphate Dehydrogenase Deficiency, G6PD Variants and Ovalocytosis in Human Populations. 1st Edn., Oxford University Press, Oxford, UK., ISBN: 0195036344.

Long, W.K., S.W. Wilson and E.P. Frenkel, 1967. Associations between red cell glucose-6-phosphate dehydrogenase variants and vascular diseases. Am. J. Hum. Genet., 19: 35-53.
Direct Link  |  

Matsui, R., S. Xu, K.A. Maitland, R. Mastroianni and J.A. Leopold et al., 2006. Glucose-6-phosphate dehydrogenase deficiency decreases vascular superoxide and atherosclerotic lesions in apolipoprotein E-mice. Arteriosclerosis Thrombosis Vascular Biol., 26: 910-916.
Direct Link  |  

Meloni, L., M.R. Manca, I. Loddo, G. Cioglia and P. Cocco et al., 2008. Glucose-6-phosphate dehydrogenase deficiency protects against coronary heart disease. J. Inherited Metab. Dis., 31: 412-417.
CrossRef  |  Direct Link  |  

Muntoni, S., 2001. Genetic Influences on Serum LDL Levels and on Type 1 Diabetes Incidence in Sardinia. In: Nutrition and Fitness: Diet, Genes, Physical Activity and Health, Simopoulos, A.P., D.C. Washington and K.N. Pavlou (Eds.). Karger Publishers, Basel, Switzerland, pp: 76-82.

Muntoni, S., 2003. G-6-PD deficiency: A naturally-occurringmodel of HMG-CoA reductase restraint. Ann. Nutr. Metab, 47: 229-254.

Muntoni, S., B. Batetta, S. Dessi, S.A. Muntoni and P. Pani, 1992. Serum lipoprotein profile in the Mediterranean variant of glucose-6-phosphate dehydrogenase deficiency. Eur. J. Epidemiol., 8: 48-53.
CrossRef  |  Direct Link  |  

Nezhad, S.K., A. Mashayekhi, S.R. Khatami, S.A.E.I.D. Daneshmand and F. Fahmi et al., 2009. Prevalence and molecular identification of Mediterranean glucose-6-phosphate dehydrogenase deficiency in Khuzestan Province, Iran. Iran. J. Public Health, 38: 127-131.
Direct Link  |  

Oluboyede, O.A., G.J. Esan, T.I. Francis and L. Luzzatto, 1979. Genetically determined deficiency of glucose 6-phosphate dehydrogenase (type-A-) is expressed in the liver. J. Lab. Clini. Med., 93: 783-789.
PubMed  |  Direct Link  |  

Sanna, E., R. Bruno, G.G. Cosseddu, G. Floris and A. Salis et al., 1990. Present-day G-6-PD deficit in Sardinia with respect to malarial morbidity and mortality in the past. Mag. Morphol. Anthropologie, 1: 257-267.
Direct Link  |  

Scandinavian Simvastatin Survival Study Group, 1994. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival study (4S). Lancet, 344: 1383-1389.
CrossRef  |  PubMed  |  

Shepherd, J., S.M. Cobbe, I. Ford, C.G. Isles and A.R. Lorimer et al., 1995. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N. Engl. J. Med., 333: 1301-1308.
CrossRef  |  PubMed  |  Direct Link  |